Denbufylline
CAS : 57076-71-8
Ref. 3D-FD21036
1mg | 184,00 € | ||
2mg | 294,00 € | ||
5mg | 414,00 € | ||
10mg | 613,00 € | ||
25mg | 1.052,00 € |
Informations sur le produit
- 1,3-Di-n-butyl-7-[2'-oxopropyl)xanthineBRL 308921,3-Dibutyl-3,7-dihydro-7-(2-oxopropyl)-1H-purine-2,6-dione
- 1,3-Di-n-butyl-7-(2-oxopropyl)xanthine
- 1,3-Dibutyl-3,7-dihydro-7-(2-oxopropyl)-1H-purine-2,6-dione
- 1,3-dibutyl-7-(2-oxopropyl)-3,7-dihydro-1H-purine-2,6-dione
- 1H-Purine-2,6-dione, 1,3-dibutyl-3,7-dihydro-7-(2-oxopropyl)-
- 1H-Purine-2,6-dione, 3,7-dihydro-1,3-dibutyl-7-(2-oxopropyl)-
- 3,7-Dihydro-1,3-dibutyl-7-(2-oxopropyl)-1H-purine-2,6-dione
- 7-Acetonyl-1,3-dibutylxanthine
- Brl 30892
- Denbufilina
- Voir d'autres synonymes
- Denbufilina [Spanish]
- Denbufylline [INN:BAN]
- Denbufyllinum
- Denbufyllinum [Latin]
- Denbutyline
- Denbutylline
- Unii-04B949Ko6F
Denbufylline is a chiral compound that acts as an agonist of the 2-adrenergic receptor. It also has been shown to increase calcium levels in the cytosol, which may be due to its ability to inhibit phosphodiesterase. Denbufylline has been shown to have a number of pharmacological effects, including stimulation of contractions in rat heart and detrusor muscle, and inhibition of intestinal motility. The drug also increases nucleotide levels in cardiac tissue, but not in skeletal muscle or liver tissue. Denbufylline is metabolized by cytochrome P450 enzymes into metabolites with similar pharmacological properties. This drug has been shown to cause bradycardia and hypotension in humans at high doses.
Propriétés chimiques
Question d’ordre technique sur : 3D-FD21036 Denbufylline
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages